Insights into the treatment of inflammatory bowel disease in pregnancy
Open Access
- 1 January 2019
- journal article
- review article
- Published by SAGE Publications in Therapeutic Advances in Gastroenterology
- Vol. 12
Abstract
Patients diagnosed with inflammatory bowel disease (IBD) are most commonly diagnosed in late adolescence or early adulthood, with half of patients being diagnosed before age 32, thus impacting peak years of reproduction and family planning. While controlled IBD has no negative effects on the ability to conceive, there is overall a trend towards voluntary childlessness due to patients’ concerns for adverse fetal outcomes from underlying IBD and from adverse medication effects. Active disease at the time of conception is associated with worsening disease activity during pregnancy and carries a higher risk of poor fetal outcomes. It is therefore important to maintain remission during pregnancy, which is often achieved with pharmacologic therapy. The goal of this paper is to provide a comprehensive review of the current literature and safety data for pharmacologic treatment of IBD in pregnancy, in breastfeeding women, and in men planning to have children.Keywords
This publication has 126 references indexed in Scilit:
- Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel diseaseGut, 2013
- Drugs and Lactation Database: LactMedJournal of Electronic Resources in Medical Libraries, 2012
- Corticosteroid use during pregnancy and risk of orofacial cleftsCanadian Medical Association Journal, 2011
- Successful use of infliximab for perianal Crohnʼs disease in pregnancyInflammatory Bowel Diseases, 2011
- Hypoglycaemic seizure and neonatal acute adrenal insufficiency after maternal exposure to prednisone during pregnancy: a case reportEuropean Journal of Pediatrics, 2009
- Fertility and Reproduction in Male Patients with Ankylosing Spondylitis Treated with Infliximab: Table 1.The Journal of Rheumatology, 2009
- In Utero Exposure to Di( n -butyl) Phthalate and Testicular Dysgenesis: Comparison of Fetal and Adult End Points and Their Dose SensitivityEnvironmental Health Perspectives, 2007
- Outcome of Pregnancy in Women Receiving Infliximab for the Treatment of Crohn's Disease and Rheumatoid ArthritisAmerican Journal of Gastroenterology, 2004
- SulfasalazineDigestive Diseases and Sciences, 1983
- Incidence of sulphasalazine-induced male infertility.Gut, 1981